- Ondero Met 2.5 mg/500 mg Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation helps improve insulin sensitivity and reduces hepatic glucose production.
- Patients using Ondero Met 2.5 mg/500 mg Tablet may experience fewer episodes of hypoglycemia compared to other antidiabetic medications.
- Ondero Met 2.5 mg/500 mg Tablet supports weight management, making it beneficial for overweight individuals with diabetes.
- This medication can be used in conjunction with diet and exercise to enhance overall glycemic control.
- Ondero Met 2.5 mg/500 mg Tablet is suitable for adults who require additional support in managing their blood glucose levels.
- The combination of Metformin and Linagliptin in Ondero Met 2.5 mg/500 mg Tablet provides a dual mechanism of action for better diabetes management.
- Using Ondero Met 2.5 mg/500 mg Tablet may help prevent long-term complications associated with uncontrolled diabetes.
- Patients can benefit from the convenience of a single tablet that combines two effective antidiabetic agents.
- Ondero Met 2.5 mg/500 mg Tablet is often recommended for those who have not achieved adequate control with monotherapy.
- This therapy can help improve overall metabolic health in individuals with Type 2 diabetes.
- Regular use of Ondero Met 2.5 mg/500 mg Tablet can lead to improved quality of life for diabetic patients.
Ondero Met 2.5 mg/500 mg Tablet - Strip of 10
Compositions : Linagliptin 2.5mg + Metformin Hydrochloride 500mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Lupin Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Ondero Met 2.5 mg/500 mg Tablet is a pharmaceutical formulation specifically designed for the management of Type 2 diabetes mellitus. This medication combines two active ingredients, Metformin and Linagliptin, which work synergistically to help control blood sugar levels effectively. Ondero Met 2.5 mg/500 mg Tablet is classified under the therapeutic category of antidiabetic agents, making it a vital option for patients struggling with diabetes management. The key composition of Ondero Met 2.5 mg/500 mg Tablet includes 2.5 mg of Linagliptin and 500 mg of Metformin, both of which play crucial roles in glucose regulation. Metformin primarily works by decreasing hepatic glucose production and enhancing insulin sensitivity, while Linagliptin inhibits the enzyme DPP-4, leading to increased incretin levels that help regulate blood sugar levels post-meal. The primary purpose of Ondero Met 2.5 mg/500 mg Tablet is to improve glycemic control in adults with Type 2 diabetes, especially when diet and exercise alone are insufficient. By utilizing Ondero Met 2.5 mg/500 mg Tablet, patients can experience better management of their blood glucose levels, thereby reducing the risk of diabetes-related complications. This combination therapy not only aids in lowering blood sugar but also has a favorable safety profile, making Ondero Met 2.5 mg/500 mg Tablet a preferred choice among healthcare providers for diabetes treatment. Overall, Ondero Met 2.5 mg/500 mg Tablet represents a significant advancement in diabetes care, providing patients with an effective tool to manage their condition and improve their quality of life.
Product Details
Ondero Met 2.5 mg/500 mg Tablet works through a combination of two mechanisms to effectively manage blood sugar levels in patients with Type 2 diabetes. The active ingredients, Metformin and Linagliptin, complement each other to provide comprehensive glycemic control.
- Metformin: Reduces glucose production in the liver and enhances insulin sensitivity in peripheral tissues.
- Linagliptin: Inhibits the DPP-4 enzyme, leading to increased levels of incretin hormones that promote insulin secretion in response to meals.
- This dual action helps lower fasting and postprandial blood glucose levels.
- By improving insulin action and reducing glucose output, Ondero Met 2.5 mg/500 mg Tablet aids in achieving better glycemic control.
- The combination also minimizes the risk of hypoglycemia compared to other diabetes medications.
- Overall, Ondero Met 2.5 mg/500 mg Tablet provides a balanced approach to managing Type 2 diabetes effectively.
- Ondero Met 2.5 mg/500 mg Tablet should be taken orally with food to minimize gastrointestinal discomfort.
- The recommended starting dosage is typically one tablet taken once daily, as prescribed by a healthcare provider.
- Dosage may be adjusted based on individual blood glucose levels and tolerance to the medication.
- It is essential to take Ondero Met 2.5 mg/500 mg Tablet at the same time each day for optimal results.
- Patients should not exceed the prescribed dosage without consulting their healthcare provider.
- The duration of treatment with Ondero Met 2.5 mg/500 mg Tablet will depend on individual patient needs and response to therapy.
- Regular monitoring of blood sugar levels is recommended while using this medication.
- If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Ondero Met 2.5 mg/500 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication in controlling blood sugar levels.
- Avoid skipping meals to prevent fluctuations in blood glucose levels while on Ondero Met 2.5 mg/500 mg Tablet.
- Stay hydrated by drinking plenty of water throughout the day; proper hydration supports overall metabolic function.
- Regularly monitor your blood sugar levels as advised by your healthcare provider to track your progress effectively.
Safety Advice
Side Effects
- Common side effects of Ondero Met 2.5 mg/500 mg Tablet include nausea and headache.
- Some patients may experience dizziness or tremors while taking this medication.
- Weight gain can occur in some individuals using Ondero Met 2.5 mg/500 mg Tablet.
- Hypoglycemia (low blood sugar) may happen, particularly if combined with other antidiabetic medications or alcohol.
- Serious side effects include lactic acidosis, which requires immediate medical attention if symptoms like rapid breathing or persistent nausea occur.
- Consult a healthcare provider if side effects persist or worsen over time.
Precautions and Warnings
- Ondero Met 2.5 mg/500 mg Tablet should not be used by individuals with severe kidney impairment or hypersensitivity to its components.
- Patients should inform their doctor about any history of pancreatitis before starting this medication.
- Caution is advised when using Ondero Met 2.5 mg/500 mg Tablet during pregnancy or breastfeeding; consult a healthcare provider for guidance.
- Avoid alcohol consumption while taking this medication due to the risk of hypoglycemia and lactic acidosis.
- Regular monitoring of kidney function is recommended during treatment with Ondero Met 2.5 mg/500 mg Tablet.
- Patients should discuss any other medications they are taking to avoid potential drug interactions.
FAQs
Ondero Met 2.5 mg/500 mg Tablet is primarily used for managing Type 2 diabetes mellitus by helping to control blood sugar levels.
2. How should I take Ondero Met 2.5 mg/500 mg Tablet?
Take Ondero Met 2.5 mg/500 mg Tablet orally with food to minimize stomach upset, following your healthcare provider's dosage recommendations.
3. What are the common side effects of Ondero Met 2.5 mg/500 mg Tablet?
Common side effects include nausea, headache, dizziness, and potential weight gain; consult your doctor if these persist.
4. Are there any precautions I should take while using Ondero Met 2.5 mg/500 mg Tablet?
Yes, avoid alcohol and inform your doctor about any kidney issues or other medications you are taking to prevent interactions.
5. Can I use Ondero Met 2.5 mg/500 mg Tablet during pregnancy?
Consult your healthcare provider before using Ondero Met 2.5 mg/500 mg Tablet during pregnancy or breastfeeding for safety advice.
6. What should I do if I miss a dose of Ondero Met 2.5 mg/500 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to the next scheduled dose; do not double up.
7. How does Ondero Met 2.5 mg/500 mg Tablet work?
Ondero Met 2.5 mg/500 mg Tablet combines two active ingredients that work together to lower blood sugar levels by improving insulin sensitivity and reducing glucose production.
Instructions
Directions for Use
Storage and Disposal
- Store below 30°C in a cool, dry place away from sunlight and moisture.
- Keep out of reach of children.
- Do not use after expiry date.
- Dispose of unused medicines as per local guidelines.
More Information
| SKU | 40277 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Ondero Met 2.5 mg/500 mg Tablet is a pharmaceutical formulation specifically designed for the management of Type 2 diabetes mellitus. This medication combines two active ingredients, Metformin and Linagliptin, which work synergistically to help control blood sugar levels effectively. Ondero Met 2.5 mg/500 mg Tablet is classified under the therapeutic category of antidiabetic agents, making it a vital option for patients struggling with diabetes management. The key composition of Ondero Met 2.5 mg/500 mg Tablet includes 2.5 mg of Linagliptin and 500 mg of Metformin, both of which play crucial roles in glucose regulation. Metformin primarily works by decreasing hepatic glucose production and enhancing insulin sensitivity, while Linagliptin inhibits the enzyme DPP-4, leading to increased incretin levels that help regulate blood sugar levels post-meal. The primary purpose of Ondero Met 2.5 mg/500 mg Tablet is to improve glycemic control in adults with Type 2 diabetes, especially when diet and exercise alone are insufficient. By utilizing Ondero Met 2.5 mg/500 mg Tablet, patients can experience better management of their blood glucose levels, thereby reducing the risk of diabetes-related complications. This combination therapy not only aids in lowering blood sugar but also has a favorable safety profile, making Ondero Met 2.5 mg/500 mg Tablet a preferred choice among healthcare providers for diabetes treatment. Overall, Ondero Met 2.5 mg/500 mg Tablet represents a significant advancement in diabetes care, providing patients with an effective tool to manage their condition and improve their quality of life.
- Ondero Met 2.5 mg/500 mg Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation helps improve insulin sensitivity and reduces hepatic glucose production.
- Patients using Ondero Met 2.5 mg/500 mg Tablet may experience fewer episodes of hypoglycemia compared to other antidiabetic medications.
- Ondero Met 2.5 mg/500 mg Tablet supports weight management, making it beneficial for overweight individuals with diabetes.
- This medication can be used in conjunction with diet and exercise to enhance overall glycemic control.
- Ondero Met 2.5 mg/500 mg Tablet is suitable for adults who require additional support in managing their blood glucose levels.
- The combination of Metformin and Linagliptin in Ondero Met 2.5 mg/500 mg Tablet provides a dual mechanism of action for better diabetes management.
- Using Ondero Met 2.5 mg/500 mg Tablet may help prevent long-term complications associated with uncontrolled diabetes.
- Patients can benefit from the convenience of a single tablet that combines two effective antidiabetic agents.
- Ondero Met 2.5 mg/500 mg Tablet is often recommended for those who have not achieved adequate control with monotherapy.
- This therapy can help improve overall metabolic health in individuals with Type 2 diabetes.
- Regular use of Ondero Met 2.5 mg/500 mg Tablet can lead to improved quality of life for diabetic patients.
Ondero Met 2.5 mg/500 mg Tablet works through a combination of two mechanisms to effectively manage blood sugar levels in patients with Type 2 diabetes. The active ingredients, Metformin and Linagliptin, complement each other to provide comprehensive glycemic control.
- Metformin: Reduces glucose production in the liver and enhances insulin sensitivity in peripheral tissues.
- Linagliptin: Inhibits the DPP-4 enzyme, leading to increased levels of incretin hormones that promote insulin secretion in response to meals.
- This dual action helps lower fasting and postprandial blood glucose levels.
- By improving insulin action and reducing glucose output, Ondero Met 2.5 mg/500 mg Tablet aids in achieving better glycemic control.
- The combination also minimizes the risk of hypoglycemia compared to other diabetes medications.
- Overall, Ondero Met 2.5 mg/500 mg Tablet provides a balanced approach to managing Type 2 diabetes effectively.
- Ondero Met 2.5 mg/500 mg Tablet should be taken orally with food to minimize gastrointestinal discomfort.
- The recommended starting dosage is typically one tablet taken once daily, as prescribed by a healthcare provider.
- Dosage may be adjusted based on individual blood glucose levels and tolerance to the medication.
- It is essential to take Ondero Met 2.5 mg/500 mg Tablet at the same time each day for optimal results.
- Patients should not exceed the prescribed dosage without consulting their healthcare provider.
- The duration of treatment with Ondero Met 2.5 mg/500 mg Tablet will depend on individual patient needs and response to therapy.
- Regular monitoring of blood sugar levels is recommended while using this medication.
- If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Ondero Met 2.5 mg/500 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication in controlling blood sugar levels.
- Avoid skipping meals to prevent fluctuations in blood glucose levels while on Ondero Met 2.5 mg/500 mg Tablet.
- Stay hydrated by drinking plenty of water throughout the day; proper hydration supports overall metabolic function.
- Regularly monitor your blood sugar levels as advised by your healthcare provider to track your progress effectively.
Side Effects
- Common side effects of Ondero Met 2.5 mg/500 mg Tablet include nausea and headache.
- Some patients may experience dizziness or tremors while taking this medication.
- Weight gain can occur in some individuals using Ondero Met 2.5 mg/500 mg Tablet.
- Hypoglycemia (low blood sugar) may happen, particularly if combined with other antidiabetic medications or alcohol.
- Serious side effects include lactic acidosis, which requires immediate medical attention if symptoms like rapid breathing or persistent nausea occur.
- Consult a healthcare provider if side effects persist or worsen over time.
Precautions and Warnings
- Ondero Met 2.5 mg/500 mg Tablet should not be used by individuals with severe kidney impairment or hypersensitivity to its components.
- Patients should inform their doctor about any history of pancreatitis before starting this medication.
- Caution is advised when using Ondero Met 2.5 mg/500 mg Tablet during pregnancy or breastfeeding; consult a healthcare provider for guidance.
- Avoid alcohol consumption while taking this medication due to the risk of hypoglycemia and lactic acidosis.
- Regular monitoring of kidney function is recommended during treatment with Ondero Met 2.5 mg/500 mg Tablet.
- Patients should discuss any other medications they are taking to avoid potential drug interactions.
Ondero Met 2.5 mg/500 mg Tablet is primarily used for managing Type 2 diabetes mellitus by helping to control blood sugar levels.
2. How should I take Ondero Met 2.5 mg/500 mg Tablet?
Take Ondero Met 2.5 mg/500 mg Tablet orally with food to minimize stomach upset, following your healthcare provider's dosage recommendations.
3. What are the common side effects of Ondero Met 2.5 mg/500 mg Tablet?
Common side effects include nausea, headache, dizziness, and potential weight gain; consult your doctor if these persist.
4. Are there any precautions I should take while using Ondero Met 2.5 mg/500 mg Tablet?
Yes, avoid alcohol and inform your doctor about any kidney issues or other medications you are taking to prevent interactions.
5. Can I use Ondero Met 2.5 mg/500 mg Tablet during pregnancy?
Consult your healthcare provider before using Ondero Met 2.5 mg/500 mg Tablet during pregnancy or breastfeeding for safety advice.
6. What should I do if I miss a dose of Ondero Met 2.5 mg/500 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to the next scheduled dose; do not double up.
7. How does Ondero Met 2.5 mg/500 mg Tablet work?
Ondero Met 2.5 mg/500 mg Tablet combines two active ingredients that work together to lower blood sugar levels by improving insulin sensitivity and reducing glucose production.
Directions for Use
Storage and Disposal
- Store below 30°C in a cool, dry place away from sunlight and moisture.
- Keep out of reach of children.
- Do not use after expiry date.
- Dispose of unused medicines as per local guidelines.
| SKU | 40277 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account